































Sir2 is a NAD-dependent deacetylase and promotes 
longevity in many organisms [1]. In mammals, there are 
seven Sir2 homologues called sirtuins (SIRT1-7), which 
regulate various biological functions in aging, 
metabolism and disease. Among of them, SIRT3, 
SIRT4 and SIRT5 are believed to be localized in 
mitochondria [2]. SIRT3 is the most characterized 
mitochondrial sirtuin. SIRT3 interacts with acetyl-CoA 
synthetase 2 (ACS2) and deacetylates Lys-642 in vitro 
and in vivo. Deacetylation of ACS2 by SIRT3 up-
regulates the acetyl-CoA synthesis activity [3, 4]. 
SIRT3 also deacetylates NDUFA9, one of the electron 
transport chain complex1 components to regulate ATP 
levels [5].  SIRT4 ADP-ribosylates glutamate dehydro-
genase (GDH) and controls insulin secretion in response 
to calorie restriction [6, 7]. GDH is also deacetylated by 
SIRT3, but its physiological significance is unknown 
[8]. These findings show that SIRT3 and SIRT4 directly 
control the activity of metabolic enzymes in 
mitochondria and play an important role in energy 




























































Recently we reported that SIRT5 is localized in 
mitochondria matrix and regulates the urea cycle 
through the deacetylation of CPS1 (Figure 1) [9]. By 
systemic sub-fractionation of isolated mitochondria 
from mouse liver, we found SIRT5 was also localized in 
the matrix fraction, as well as SIRT3 and SIRT4. This 
finding corresponded with the fact that SIRT5 was 
cleaved in the N-terminus at a typical consensus 
sequence recognized by mitochondria matrix peptidase. 
To identify SIRT5-interacting proteins, we developed In 
vitro SIRT5-Flag affinity purification, and found CPS1 
as a SIRT5-binding protein. CPS1 is an enzyme which 
mediates the first step of urea cycle. CPS1 is reported to 
be acetylated at multiple lysine residues [10], however 
the biological function of acetylation was unclear. 
Using an in vitro deacetylation assay, we revealed that 
SIRT5 could deacetylate CPS1 in a NAD-dependent 
manner and this deacetylation increased CPS1 
enzymatic activity. Indeed, SIRT5 deficient mice have 
~30% lower CPS1 activity compared to wild type mice. 
During fasting conditions, SIRT5 deficient mice failed 
to up-regulate CPS1 activity and thereby resulted in 
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during calorie restriction or a high protein diet.  
 
How does food limitation activates the SIRT5? A 
previous study showed fasting induced the translocation 
of NAD biosynthesis enzyme Nampt, to mitochondria 
and elevated the NAD levels in mitochondria [11]. 
Although we did not detect the translocation of Nampt 
to mitochondria in mouse liver, we observed the 
increase of Nampt protein in the cytoplasm and the 
increase of NAD level in the mitochondria. We 
hypothesize that the elevation of Nampt in cytoplasm 
increase the NMN pool in the cytoplasm and NMN 
consequently translocates into the mitochondria. In 
mitochondria, Nmnat3 converts NMN to NAD, the next 
step in NAD biosynthesis, to activate SIRT5 (Figure 1). 
However questions remain. For example, does Nampt 
translocation to mitochondria take place in other 
tissues? How is NMN incorporated into mitochondria?  
 
In mitochondria, ~400 proteins have been shown to be 
acetylated [10]. However little is known about their 
biological significance. As SIRT5 is expressed 
ubiquitously in various tissues, SIRT5 probably has 
other substrates besides CPS1. In fact, we also 





























same strategy (our unpublished data). Compared to 
deacetylation, little is known about the mechanism of 
acetylation of mitochondrial proteins. Is acetylation in 
the mitochondria enzymatic? If so, how many acetyl-
transferase are there, and what is the specificity? More 
studies will be necessary to understand the biological 
meaning of acetylation/deacetylation interplay in the 
mitochondria. 
 
Interestingly, SIRT4 ADP-ribosylates GDH, which 
mediates the oxidative deamination step during 
ammonia detoxification and represses GDH activity 
(Figure 2). Our findings show that SIRT5 controls the 
subsequent step of the ammonia detoxification pathway. 
Furthermore, OTC, an enzyme mediating the second 
step of the urea cycle in the mitochondria matrix, was 
also recently reported to be regulated by reversible 
acetylation of Lysine-88 [12]. Deacetylation of OTC 
Lysine-88 increases the OTC enzymatic activity. In our 
study, no obvious change was observed in OTC activity 
in SIRT3, SIRT4 and SIRT5 deficient mice under normal 
conditions. However, a more detailed study under 
stressed condition, such as fasting or calorie restriction 
may reveal the roles of mitochondrial sirtuins in OTC 
deacetylation and the coordination of mitochondrial 

































































Our findings uncovered that, SIRT5 also has a pivotal 
role in the metabolic adaptations during dietary shifts as 
well as other sirtuins and co-factor NAD biosynthesis 
pathway is also the important regulator of these 
processes. Drugs that activate SIRT5 may have 
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